Please login to the form below

Not currently logged in
PMLiVE Top Pharma List


The Top Pharma List's top 50 pharmaceutical products by global sales ranking is compiled from GlobalData's pharmaceutical revenue figures. Nexium was produced by AstraZeneca and Daiichi Sankyo.

Technology trends facing pharma in 2013

Technology trends facing pharma in 2013 For example, AstraZeneca was a pioneer in the sector when it added serial numbers to Nexium (esomeprazole) to help track products through the supply chain and help combat medicines counterfeiting. . ... The Nexium dataset is now by far the largest in AZ,

Pharma deals during October 2012

Pharma deals during October 2012 As a further dimension to their relationship, the companies also announced a co-promotion agreement in the US for AZ's Nexium (esomeprazole magnesium) for gastroesophageal reflux disease (GERD). Many patients

Eisai enlists Astro Boy for medicines adherence mobile website

The proton pump inhibitor, which competes with AstraZeneca's Nexium (esomeprazole), is currently in phase IV trials examining its effect on quality of life, data from which is expected next year. .

More job cuts for AstraZeneca in US

including blood pressure drug Atacand (candesartan cilexetil), schizophrenia drug Seroquel (quetiapine)  and gastrointestinal treatment Nexium (esomeprazole).

AZ's Q3 income up as sales stay flat

Products affected by generic competition included heartburn treatment Nexium (esomeprazole), with sales falling by 16 per cent in the US and 50 per cent in Western Europe.

[ Previous 5 results ] 2 3 4 5 6 7 8 9 10 11 [ Next 5 results ]

COVID-19 Updates and Daily News

Featured jobs


Add my company

Viseven is a full cycle digital agency with 10 years expertise in developing content for the global pharmaceutical market delivering...

Latest intelligence

The search for treatments for Parkinson’s disease
The research requires resilience but pharma is urged to ‘keep innovating, keep trying’...
Margot Hannah, OPEN Health - A personal perspective of LGBT+ and diversity.
Ditch the Label – it’s just me....
The impact of COVID-19 on clinical trials
As all industry sectors work to assess both the impact and the optimal path forward, the effects are expected to be diverse and long-lasting...